BM86 Immunomodulator Vials
Archived on April 11, 2026. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 3:00 PM CDT
- Posted
- March 24, 2026
- Notice type
- Combined Synopsis/Solicitation
- Set-aside
- No Set aside used
- NAICS
- 325412: Pharmaceutical Preparation Manufacturing
- Agency
- Department of AgricultureANIMAL AND PLANT HEALTH INSPECTION SERVICE
Notice details
- Office
- MRPBS MINNEAPOLIS MN
- Place of performance
- Laredo, Texas, 78041
- PSC
- 6505: DRUGS AND BIOLOGICALS
- Last updated
- Nov 2, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- 12639526Q0079
- Notice ID
- ef712678c3374eaba539cac266be6273
Description
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Part 12. This announcement constitutes the only solicitation. Quotations are being requested and a separate written solicitation will not be issued.
The intended source for this acquisition is Zoetis Inc.
The proposed contractor, Zoetis Inc. has exclusive property rights to this product and no alternatives are available to meet USDA requirements.
Solicitation number 12639526Q0079 is issued as a Request for Quotation (RFQ) for 1,400 BM86 Immunomodulator 10DS 20ML Vials
This acquisition is not set-aside for small business concerns. The applicable North American Industry Classification Standard Code is 325412 The small business size standard is 1,300 employees This acquisition is an unrestricted requirement. All responsible sources may submit a quotation which will be considered by the agency.
Award Overview
Contacts
Contracting Officer
Primary Contact
Documents
Lifecycle
- 3Version 3Combined Synopsis/SolicitationArchivedCurrent
BM86 Immunomodulator Vials
Similar Opportunities
Additional Details
Solicitation Number
12639526Q0079
Archive Date
Apr 11, 2026
Office Address
MINNEAPOLIS, MN, 55401